Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 3 records, 1 pages
Search For: Nanomaterial-Based Adjuvants Vaccine
Global Nanomaterial-Based Adjuvants Vaccine Supply, Demand and Key Producers, 2024-2030
09 Oct 2024
Pharma & Healthcare
Nanomaterial-Based Adjuvants Vaccine
Nanoparticles (NPs) can act as adjuvants for vaccines, hence they are referred to as a nano-adjuvant (NA). NPs can either encapsulate or adsorb the vaccine antigen or DNA in an appropriate formulation, thus increasing stability, cellular uptake, and immunogenicity.
USD4480.00
Add To Cart
Global Nanomaterial-Based Adjuvants Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
09 Oct 2024
Pharma & Healthcare
Nanomaterial-Based Adjuvants Vaccine
Nanoparticles (NPs) can act as adjuvants for vaccines, hence they are referred to as a nano-adjuvant (NA). NPs can either encapsulate or adsorb the vaccine antigen or DNA in an appropriate formulation, thus increasing stability, cellular uptake, and immunogenicity.
USD3480.00
Add To Cart
Global Nanomaterial-Based Adjuvants Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
18 Mar 2023
Pharma & Healthcare
Nanomaterial-Based Adjuvants Vaccine
According to our (Global Info Research) latest study, the global Nanomaterial-Based Adjuvants Vaccine market size was valued at USD 60800 million in 2022 and is forecast to a readjusted size of USD 101890 million by 2029 with a CAGR of 7.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Nanomaterial-Based Adjuvants Vaccine
Total: 3 records, 1 pages
Nanoparticles (NPs) can act as adjuvants for vaccines, hence they are referred to as a nano-adjuvant (NA). NPs can either encapsulate or adsorb the vaccine antigen or DNA in an appropriate formulation, thus increasing stability, cellular uptake, and immunogenicity.
USD4480.00
Add To Cart
Nanoparticles (NPs) can act as adjuvants for vaccines, hence they are referred to as a nano-adjuvant (NA). NPs can either encapsulate or adsorb the vaccine antigen or DNA in an appropriate formulation, thus increasing stability, cellular uptake, and immunogenicity.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Nanomaterial-Based Adjuvants Vaccine market size was valued at USD 60800 million in 2022 and is forecast to a readjusted size of USD 101890 million by 2029 with a CAGR of 7.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>